Inherited factors for prostate cancer prostate cancer risk have proven difficult to identify. The results oflinkage analysis, the workhorse of gene finding methods for Mendelian disorders, have been notoriouslydifficult to validate. Within the past year, however, two independent studies have demonstrated that a regionon 8q24 confers a strong risk of developing sporadic prostate cancer in men of African and Europeanancestries. 8q24 is the first bona fide genetic risk locus that is responsible for an appreciable fraction ofsporadic prostate cancer cases in the general population, particularly, in African-American men. Ourhypotheses are that a genetic variant within 8q24 initiates prostate cancer and impacts the clinical featuresof the disease.The discovery of this novel locus presents the opportunity to gain deeper insight into prostate cancer biology.Although the region has been identified, the causal allele and the gene that it influences remain to bedetermined. Since 8q is one of the most frequent regions of somatic amplification in prostate cancer, we willalso have the opportunity to explore connections between the germline and somatic genomes.Understanding the genetic and molecular pathways driving prostate cancer can ultimately lead to improveddiagnostic and therapeutic capabilities. From a clinical perspective, patients can be stratified into carriers andnon-carriers of this risk allele to explore its impact on clinical variables, such as presentation and diseaseoutcomes. Our goals are to elucidate the genetic pathogenesis and the clinical impact of the 8q24 variantallele on prostate cancer.
The Specific Aims of this Project are to:
Aim 1 : To identify the causal germline allele through fine mapping of the 8q24 regionAim 2: To characterize inherited variation at 8q24 and somatic molecular associations at 8q24Aim 3: To determine the effect of the germline 8q24 variant on clinical presentation and outcomes in prostate cancer patients
Showing the most recent 10 out of 261 publications
